Intrexon | XON - Market Capitalization


Intrexon reported $1.04B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Xencor USD 1.09B 256M Dec/2025